# Zero-shot Learning of Drug Response Prediction for Preclinical Drug Screening

arXiv: https://arxiv.org/abs/2310.12996 · HTML: https://mlsanity.com/paper/2310.12996/

## Key facts

- Cited by 1 papers in the map (data through 14 Oct 2026).
- Builds on 16 of its 54 references that are in the map.
- First posted on arXiv 5 Oct 2023.

## Builds on (most cited first, 16 of 16)

- [Don't Stop Pretraining: Adapt Language Models to Domains and Tasks](https://mlsanity.com/paper/2004.10964/) (2020)
- [Moment Matching for Multi-Source Domain Adaptation](https://mlsanity.com/paper/1812.01754/) (2018)
- [Zero-Shot Learning -- A Comprehensive Evaluation of the Good, the Bad and the Ugly](https://mlsanity.com/paper/1707.00600/) (2017)
- [Statistical Aspects of Wasserstein Distances](https://mlsanity.com/paper/1806.05500/) (2018)
- [A Review of Generalized Zero-Shot Learning Methods](https://mlsanity.com/paper/2011.08641/) (2020)
- [A review of domain adaptation without target labels](https://mlsanity.com/paper/1901.05335/) (2019)
- [Exploring Categorical Regularization for Domain Adaptive Object Detection](https://mlsanity.com/paper/2003.09152/) (2020)
- [Multi-Modal Domain Adaptation for Fine-Grained Action Recognition](https://mlsanity.com/paper/2001.09691/) (2020)
- [Maximum Density Divergence for Domain Adaptation](https://mlsanity.com/paper/2004.12615/) (2020)
- [Exploring the Limits of Domain-Adaptive Training for Detoxifying Large-Scale Language Models](https://mlsanity.com/paper/2202.04173/) (2022)
- [Cross-modal Learning for Domain Adaptation in 3D Semantic Segmentation](https://mlsanity.com/paper/2101.07253/) (2021)
- [Interpretable bilinear attention network with domain adaptation improves drug-target prediction](https://mlsanity.com/paper/2208.02194/) (2022)
- [Regressive Domain Adaptation for Unsupervised Keypoint Detection](https://mlsanity.com/paper/2103.06175/) (2021)
- [Unsupervised Domain Adaptation of a Pretrained Cross-Lingual Language Model](https://mlsanity.com/paper/2011.11499/) (2020)
- [Drug cell line interaction prediction](https://mlsanity.com/paper/1812.11178/) (2018)
- [Towards a Better Model with Dual Transformer for Drug Response Prediction](https://mlsanity.com/paper/2210.17401/) (2022)

## Built on by (most cited first, 1 of 1)

- [CLDR: Contrastive Learning Drug Response Models from Natural Language Supervision](https://mlsanity.com/paper/2312.10707/) (2023)

## Abstract (arXiv)

Conventional deep learning methods typically employ supervised learning for drug response prediction (DRP). This entails dependence on labeled response data from drugs for model training. However, practical applications in the preclinical drug screening phase demand that DRP models predict responses for novel compounds, often with unknown drug responses. This presents a challenge, rendering supervised deep learning methods unsuitable for such scenarios. In this paper, we propose a zero-shot learning solution for the DRP task in preclinical drug screening. Specifically, we propose a Multi-branch Multi-Source Domain Adaptation Test Enhancement Plug-in, called MSDA. MSDA can be seamlessly integrated with conventional DRP methods, learning invariant features from the prior response data of similar drugs to enhance real-time predictions of unlabeled compounds. We conducted experiments using the GDSCv2 and CellMiner datasets. The results demonstrate that MSDA efficiently predicts drug responses for novel compounds, leading to a general performance improvement of 5-10% in the preclinical drug screening phase. The significance of this solution resides in its potential to accelerate the drug discovery process, improve drug candidate assessment, and facilitate the success of drug discovery.
